While normoglycemic participants with obesity had the greatest degree of metabolic insulin resistance and microvascular insulin resistance compared to the other two groups with essentially no increase in MBV following insulin, there is a clear heterogeneity in microvascular insulin responses in our study population. The gene discussed is INS; the disease is Obesity.